India, July 24 -- Natco Pharma announced that the U.S.FDA has issued Establishment Inspection Report (EIR) for the API facility located in Mekaguda on July 24 2025.
Published by HT Digital Content Services with permission from Pivotal Sources....
To read the full article or to get the complete feed from this publication, please Contact Us.
